235 related articles for article (PubMed ID: 24335160)
1. Taking advantage of physiological proteolytic processing of the prion protein for a therapeutic perspective in prion and Alzheimer diseases.
Béland M; Roucou X
Prion; 2014; 8(1):106-10. PubMed ID: 24335160
[TBL] [Abstract][Full Text] [Related]
2. The P's and Q's of cellular PrP-Aβ interactions.
Westaway D; Jhamandas JH
Prion; 2012; 6(4):359-63. PubMed ID: 22874673
[TBL] [Abstract][Full Text] [Related]
3. Roles of endoproteolytic α-cleavage and shedding of the prion protein in neurodegeneration.
Altmeppen HC; Prox J; Puig B; Dohler F; Falker C; Krasemann S; Glatzel M
FEBS J; 2013 Sep; 280(18):4338-47. PubMed ID: 23413979
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's and prion diseases: distinct pathologies, common proteolytic denominators.
Checler F; Vincent B
Trends Neurosci; 2002 Dec; 25(12):616-20. PubMed ID: 12446128
[TBL] [Abstract][Full Text] [Related]
5. Decoding the function of the N-terminal tail of the cellular prion protein to inspire novel therapeutic avenues for neurodegenerative diseases.
Iraci N; Stincardini C; Barreca ML; Biasini E
Virus Res; 2015 Sep; 207():62-8. PubMed ID: 25456402
[TBL] [Abstract][Full Text] [Related]
6. An optimized Western blot assay provides a comprehensive assessment of the physiological endoproteolytic processing of the prion protein.
Vanni I; Iacobone F; D'Agostino C; Giovannelli M; Pirisinu L; Altmeppen HC; Castilla J; Torres JM; Agrimi U; Nonno R
J Biol Chem; 2023 Feb; 299(2):102823. PubMed ID: 36565989
[TBL] [Abstract][Full Text] [Related]
7. Shedding light on prion disease.
Glatzel M; Linsenmeier L; Dohler F; Krasemann S; Puig B; Altmeppen HC
Prion; 2015; 9(4):244-56. PubMed ID: 26186508
[TBL] [Abstract][Full Text] [Related]
8. Common therapeutic strategies for prion and Alzheimer's diseases.
Elezgarai SR; Biasini E
Biol Chem; 2016 Nov; 397(11):1115-1124. PubMed ID: 27279060
[TBL] [Abstract][Full Text] [Related]
9. Regulation of betaAPP and PrPc cleavage by alpha-secretase: mechanistic and therapeutic perspectives.
Vincent B; Cisse MA; Sunyach C; Guillot-Sestier MV; Checler F
Curr Alzheimer Res; 2008 Apr; 5(2):202-11. PubMed ID: 18393805
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Amyloid β Oligomer Binding to Neurons and Neurotoxicity by the Prion Protein-mGluR5 Complex.
Beraldo FH; Ostapchenko VG; Caetano FA; Guimaraes AL; Ferretti GD; Daude N; Bertram L; Nogueira KO; Silva JL; Westaway D; Cashman NR; Martins VR; Prado VF; Prado MA
J Biol Chem; 2016 Oct; 291(42):21945-21955. PubMed ID: 27563063
[TBL] [Abstract][Full Text] [Related]
11. α-Cleavage of cellular prion protein.
Liang J; Kong Q
Prion; 2012; 6(5):453-60. PubMed ID: 23052041
[TBL] [Abstract][Full Text] [Related]
12. Aggregation and amyloid fibril formation induced by chemical dimerization of recombinant prion protein in physiological-like conditions.
Roostaee A; Côté S; Roucou X
J Biol Chem; 2009 Nov; 284(45):30907-16. PubMed ID: 19710507
[TBL] [Abstract][Full Text] [Related]
13. Protein Misfolding in Prion and Prion-Like Diseases: Reconsidering a Required Role for Protein Loss-of-Function.
Leighton PL; Allison WT
J Alzheimers Dis; 2016 Jul; 54(1):3-29. PubMed ID: 27392869
[TBL] [Abstract][Full Text] [Related]
14. The cellular prion protein mediates neurotoxic signalling of β-sheet-rich conformers independent of prion replication.
Resenberger UK; Harmeier A; Woerner AC; Goodman JL; Müller V; Krishnan R; Vabulas RM; Kretzschmar HA; Lindquist S; Hartl FU; Multhaup G; Winklhofer KF; Tatzelt J
EMBO J; 2011 May; 30(10):2057-70. PubMed ID: 21441896
[TBL] [Abstract][Full Text] [Related]
15. Cellular prion protein and Alzheimer disease: link to oligomeric amyloid-β and neuronal cell death.
Kudo W; Petersen RB; Lee HG
Prion; 2013; 7(2):114-6. PubMed ID: 23154635
[TBL] [Abstract][Full Text] [Related]
16. Manganese upregulates cellular prion protein and contributes to altered stabilization and proteolysis: relevance to role of metals in pathogenesis of prion disease.
Choi CJ; Anantharam V; Martin DP; Nicholson EM; Richt JA; Kanthasamy A; Kanthasamy AG
Toxicol Sci; 2010 Jun; 115(2):535-46. PubMed ID: 20176619
[TBL] [Abstract][Full Text] [Related]
17. Molecular Mechanism of the Misfolding and Oligomerization of the Prion Protein: Current Understanding and Its Implications.
Singh J; Udgaonkar JB
Biochemistry; 2015 Jul; 54(29):4431-42. PubMed ID: 26171558
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
[TBL] [Abstract][Full Text] [Related]
19. The prion protein in neuroimmune crosstalk.
Salvesen Ø; Tatzelt J; Tranulis MA
Neurochem Int; 2019 Nov; 130():104335. PubMed ID: 30448564
[TBL] [Abstract][Full Text] [Related]
20. Prion protein "gamma-cleavage": characterizing a novel endoproteolytic processing event.
Lewis V; Johanssen VA; Crouch PJ; Klug GM; Hooper NM; Collins SJ
Cell Mol Life Sci; 2016 Feb; 73(3):667-83. PubMed ID: 26298290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
